{
     "PMID": "23350646",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20150818",
     "LR": "20150609",
     "IS": "1471-4159 (Electronic) 0022-3042 (Linking)",
     "VI": "125",
     "IP": "2",
     "DP": "2013 Apr",
     "TI": "Chondroitin sulfate, a major component of the perineuronal net, elicits inward currents, cell depolarization, and calcium transients by acting on AMPA and kainate receptors of hippocampal neurons.",
     "PG": "205-13",
     "LID": "10.1111/jnc.12159 [doi]",
     "AB": "Chondroitin sulfate (CS) proteoglycans (CSPGs) are the most abundant PGs of the brain extracellular matrix (ECM). Free CS could be released during ECM degradation and exert physiological functions; thus, we aimed to investigate the effects of CS on voltage- and current-clamped rat embryo hippocampal neurons in primary cultures. We found that CS elicited a whole-cell Na(+)-dependent inward current (ICS) that produced drastic cell depolarization, and a cytosolic calcium transient ([Ca(2+)]c). Those effects were similar to those elicited by alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) and kainate, were completely blocked by NBQX and CNQX, were partially blocked by GYKI, and were unaffected by MK801 and D-APV. Furthermore, ICS and AMPA currents were similarly potentiated by cyclothiazide, a positive allosteric modulator of AMPA receptors. Because CSPGs have been attributed Ca(2) (+) -dependent roles, such as neural network development, axon pathfinding, plasticity and regeneration after CNS injury, CS action after ECM degradation could be contributing to the mediation of these effects through its interaction with AMPA and kainate receptors.",
     "CI": [
          "(c) 2013 International Society for Neurochemistry."
     ],
     "FAU": [
          "Maroto, Marcos",
          "Fernandez-Morales, Jose-Carlos",
          "Padin, Juan Fernando",
          "Gonzalez, Jose C",
          "Hernandez-Guijo, Jesus M",
          "Montell, Eulalia",
          "Verges, Josep",
          "de Diego, Antonio M G",
          "Garcia, Antonio G"
     ],
     "AU": [
          "Maroto M",
          "Fernandez-Morales JC",
          "Padin JF",
          "Gonzalez JC",
          "Hernandez-Guijo JM",
          "Montell E",
          "Verges J",
          "de Diego AM",
          "Garcia AG"
     ],
     "AD": "Instituto Teofilo Hernando, Facultad de Medicina, Universidad Autonoma de Madrid, Madrid, Spain. Departamento de Farmacologia y Terapeutica, Facultad de Medicina, Universidad Autonoma de Madrid, Madrid, Spain. Instituto Teofilo Hernando, Facultad de Medicina, Universidad Autonoma de Madrid, Madrid, Spain. Departamento de Farmacologia y Terapeutica, Facultad de Medicina, Universidad Autonoma de Madrid, Madrid, Spain. Instituto Teofilo Hernando, Facultad de Medicina, Universidad Autonoma de Madrid, Madrid, Spain. Departamento de Farmacologia y Terapeutica, Facultad de Medicina, Universidad Autonoma de Madrid, Madrid, Spain. Instituto Teofilo Hernando, Facultad de Medicina, Universidad Autonoma de Madrid, Madrid, Spain. Departamento de Farmacologia y Terapeutica, Facultad de Medicina, Universidad Autonoma de Madrid, Madrid, Spain. Instituto Teofilo Hernando, Facultad de Medicina, Universidad Autonoma de Madrid, Madrid, Spain. Departamento de Farmacologia y Terapeutica, Facultad de Medicina, Universidad Autonoma de Madrid, Madrid, Spain. Pre-Clinical R&D Area, Pharmascience Division, Bioiberica, Barcelona, Spain. Pre-Clinical R&D Area, Pharmascience Division, Bioiberica, Barcelona, Spain. Instituto Teofilo Hernando, Facultad de Medicina, Universidad Autonoma de Madrid, Madrid, Spain. Departamento de Farmacologia y Terapeutica, Facultad de Medicina, Universidad Autonoma de Madrid, Madrid, Spain. Instituto Teofilo Hernando, Facultad de Medicina, Universidad Autonoma de Madrid, Madrid, Spain. Departamento de Farmacologia y Terapeutica, Facultad de Medicina, Universidad Autonoma de Madrid, Madrid, Spain. Instituto de Investigacion Sanitaria, Servicio de Farmacologia Clinica, Hospital Universitario de la Princesa. Facultad de Medicina, Universidad Autonoma de Madrid, Madrid, Spain.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20130214",
     "PL": "England",
     "TA": "J Neurochem",
     "JT": "Journal of neurochemistry",
     "JID": "2985190R",
     "RN": [
          "0 (Receptors, AMPA)",
          "0 (Receptors, Kainic Acid)",
          "9007-28-7 (Chondroitin Sulfates)"
     ],
     "SB": "IM",
     "MH": [
          "Action Potentials/*physiology",
          "Animals",
          "Cells, Cultured",
          "Chondroitin Sulfates/*metabolism",
          "Extracellular Matrix/chemistry/metabolism",
          "Hippocampus/metabolism",
          "Neurons/*metabolism",
          "Patch-Clamp Techniques",
          "Rats",
          "Rats, Sprague-Dawley",
          "Receptors, AMPA/*metabolism",
          "Receptors, Kainic Acid/*metabolism"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "AMPA receptor",
          "chondroitin sulfate",
          "hippocampal neurotransmission",
          "kainate receptor",
          "perineuronal net"
     ],
     "EDAT": "2013/01/29 06:00",
     "MHDA": "2015/08/19 06:00",
     "CRDT": [
          "2013/01/29 06:00"
     ],
     "PHST": [
          "2012/08/23 00:00 [received]",
          "2012/10/08 00:00 [revised]",
          "2013/01/15 00:00 [accepted]",
          "2013/01/29 06:00 [entrez]",
          "2013/01/29 06:00 [pubmed]",
          "2015/08/19 06:00 [medline]"
     ],
     "AID": [
          "10.1111/jnc.12159 [doi]"
     ],
     "PST": "ppublish",
     "SO": "J Neurochem. 2013 Apr;125(2):205-13. doi: 10.1111/jnc.12159. Epub 2013 Feb 14.",
     "term": "hippocampus"
}